ProtoKinetix, Incorporated (OTCMKTS:PKTX) Short Interest Update

ProtoKinetix, Incorporated (OTCMKTS:PKTX) saw a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 38,500 shares, an increase of 3,400.0% from the May 15th total of 1,100 shares. Based on an average daily volume of 274,200 shares, the days-to-cover ratio is presently 0.1 days.

ProtoKinetix Stock Performance

Shares of OTCMKTS PKTX opened at $0.01 on Thursday. The stock’s 50-day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. ProtoKinetix has a twelve month low of $0.01 and a twelve month high of $0.02.

ProtoKinetix Company Profile

ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins (AFGPs) or anti-aging glycoproteins (AAGPs). The company's AFGPs have commercial applications primarily in health care solutions, including ophthalmology, dermatology, transplants, and biomanufacturing.